Cara Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cara Therapeutics, Inc.
CIK #0001346830
EDGAR Form CIK 2011 - 2024
10-K [0001346830]
10-Q [0001346830]
3 [0001346830]
4 [0001346830]
8-K [0001346830]
D [0001346830]
SC 13G [0001346830]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bain Capital Life Sciences Opportunities III LP Cara Therapeutics Inc [2022-11-18]
Vanguard Group Inc Cara Therapeutics Inc [2022-02-09]
First Manhattan Co Cara Therapeutics Inc [2021-02-16]
Vifor International Ltd Cara Therapeutics Inc [2020-10-23]
Price T Rowe Associates Inc /MD/ Cara Therapeutics Inc [2019-02-14]
State Street Corp Cara Therapeutics Inc [2019-02-14]
State Street Corp Cara Therapeutics Inc [2018-02-14]
BlackRock Inc Cara Therapeutics Inc [2018-02-01]
BlackRock Inc Cara Therapeutics Inc [2016-01-28]
Point72 Asset Management LP Cara Therapeutics Inc [2015-12-07]
View All
Form 3/4/5 Subject 2011 - 2024
Cara Therapeutics, Inc.
Shiff Susan Ph.D.
Ives Jeffrey L.
von Moltke Lisa
Bains Harrison M Jr
Vogelbaum Martin
Posner Christopher
Goncalves Joana
Terrillion Scott
Menzaghi Frederique Ph.D.
View All
Terms | Privacy | Guide
tony@aum13f.com